Brief: Titan Pharmaceuticals - Cash Resources Are Only Sufficient To Fund Operations Through Q3 Of This Year
30/06/2020 11:57
June 30 (Reuters) - Titan Pharmaceuticals Inc TTNP.O :
* TITAN PHARMACEUTICALS - CO'S CURRENT CASH RESOURCES ARE
ONLY
SUFFICIENT TO FUND OPERATIONS THROUGH Q3 OF THIS YEAR
* TITAN PHARMACEUTICALS - HAVE ABOUT 5 MILLION AUTHORIZED
SHARES
REMAINING, INSUFFICIENT TO UNDERTAKE FINANCINGS NECESSARY TO
FUND OPERATIONS BEYOND NEXT 3 MONTHS
* TITAN PHARMA - APPROVAL OF AMENDMENT PROPOSAL TO INCREASE
NUMBER
OF AUTHORIZED SHARES OF STOCK IS "CRITICAL" TO ENABLE CO TO
CONTINUE COMMERCIAL OPERATIONS
Source text for Eikon: https://bit.ly/3eNfrqD
Further company coverage: TTNP.O
((Briefs@thomsonreuters.com;))
Recent news on Titan Pharmaceuticals
See all newsBrief: Titan Pharmaceuticals Announces $1 Million Private Placement Of Convertible Preferred Stock
Brief: Titan Pharmaceuticals- Appoints Brynner Chiam As Acting Principal Executive Officer & Acting Principal Financial Officer Of Co
U.S. STOCKS ON THE MOVE-Newmont, Monopar Therapeutics, TKO Group
Titan Pharma falls as CEO announces resignation
Brief: Titan Pharmaceuticals Enters Into Merger Agreement With Ke Sdn. Bhd.